I have just realised why RAC has skyrocketed, page-44

First 44 Last

Share
Profile

Follow
Rossi70

4,138 Posts.

1412

10/03/21

20:07

Post #: 51670538
Share

Originally posted by RaceOncology: ↑

We released price sensitive news yesterday and there were many questions and I tried to answer as many as I could. The release was technically complex (not as complex as the 80 page report it summarises) so this is understandable. Part of my job as CSO is to make scientifically complex news understandable by people who don’t happen to have a PhD in molecular biology.

On a more general note, social media has changed the world and fundamentally altered the way public companies can communicate with their shareholders. It is my strong belief that shareholders in companies like RAC are partners, not just passive sources of capital to be ignored between capital raises. Too many companies are lazily following the old ways where the only way of communicating with shareholders was via ASX releases or annual reports. A few companies have recognised that it is possible within the ASX and ASIC rules to open a two-way conversation with their shareholders using social medial and involve them in their business mission. The only thing that surprises me is how few companies make the effort to use the new communication tools available.

As a general rule I assume if someone asks me a question there are a minimum of 100 other people who have exactly the same question, but who are too scared or polite to ask. Shareholder can and do email or phone me all the time, but it is far more efficient for me to answer here on HC or twitter, facebook, linkedin, or any of the other social media platforms that allow me to communicate our shareholders.

If all this outreach has affected the SP it is hard to be certain, but I would hope that having shareholders who better understand our complex business encourages them to feel comfortable owning RAC. We have a great opportunity with Bisantrene, but nobody is going to invest in RAC if they have never heard of the company nor understands what we are trying to do.

Expand

Hi Daniel,

I have another question to ask you, If I may.

That is with yesterday fantastic announcement, about breast Cancer.

Does Bisantrene work the same way on Male population, who end up getting also breast cancer.

I do know that breast cancer affect's 90% Female and 10% Male.

Just wondering.

Thank's in Advance.

IMHO.

Regard's

Rossi70

RAC Price at posting: $3.93 Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

EBR

EBR Systems' heart pacing device on-target to reach the US market

BOE

Boss Energy ramps up as industrial-scale plant build continues; FY25 guidance of 850Klb intact

GDP grows 0.2% in June quarter, but annual growth the slowest since the 1990s

SKS

SKS secures $20M for extension works on Melbourne data centre

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

There are more pages in this discussion • 33 more messages in this thread...

First 44 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.66		Change -0.020(1.19%)		Mkt cap ! $282.8M

Open	High	Low	Value	Volume
$1.68	$1.68	$1.61	$118.5K	72.33K

Buyers (Bids)

No.	Vol.	Price($)
1	500	$1.65

Sellers (Offers)

Price($)	Vol.	No.
$1.66	601	1

View Market Depth

No.	Vol.	Price($)
1	500	1.650
1	276	1.630
1	2000	1.625
2	1025	1.620
1	3000	1.615

Price($)	Vol.	No.
1.660	601	1
1.700	6382	1
1.720	580	1
1.730	309	1
1.735	609	1

Last trade - 16.10pm 04/09/2024 (20 minute delay)

RAC (ASX) Chart

I have just realised why RAC has skyrocketed, page-44

EBR Systems' heart pacing device on-target to reach the US market

Boss Energy ramps up as industrial-scale plant build continues; FY25 guidance of 850Klb intact

GDP grows 0.2% in June quarter, but annual growth the slowest since the 1990s

SKS secures $20M for extension works on Melbourne data centre

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I have just realised why RAC has skyrocketed, page-44

Top Stories

EBR Systems' heart pacing device on-target to reach the US market

Boss Energy ramps up as industrial-scale plant build continues; FY25 guidance of 850Klb intact

GDP grows 0.2% in June quarter, but annual growth the slowest since the 1990s

SKS secures $20M for extension works on Melbourne data centre

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News